Sign in

CIK 0001512762 · Accelerated filer<br>Smaller reporting company

Coherus Oncology, Inc.

Sign in to watch
Ticker
CHRS
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
273615821
Phone
(650) 649-3530
Business address
C/O DENNIS M. LANFEAR, 333 TWIN DOLPHIN DR, SUITE 600, REDWOOD CITY, CA, 94065
Former names
Coherus BioSciences, Inc., BioGenerics, Inc.
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. UPLOAD Other SEC-generated Letter
  5. SC 13G Stake Amended Statement of Ownership
  6. S-8 Other Securities Offered to Employees in Benefit Plans
  7. S-3 Offering Registration Statement
  8. 8-K Event Results of operations · Other events
  9. 4 Grant or award Chief Scientific Officer acquired 809 shares (grant or award)
  10. 4 Grant or award Chief Medical Officer acquired 7,545 shares (grant or award)
  11. 4 Grant or award Chief Technical Officer acquired 5,900 shares (grant or award)
  12. 4 Grant or award See Remarks acquired 20,984 shares (grant or award)
  13. 4 Grant or award Chief Financial Officer acquired 6,966 shares (grant or award)
  14. CT ORDER Other Confidential Order
  15. D Other Notice of Sales of Unregistered Securities
  16. 8-K Event Other events
  17. 8-K Event Material agreement · Unregistered share sale
  18. 10-Q Report Quarterly Report
  19. 8-K Event Results of operations
  20. EFFECT Other Notice of Effectiveness

Page 31 of 47 · 923 filings